New to the family of Seramun stabilizers for HRP antibody conjugates and protein conjugates is the ready-to-use product SeramunStab® STM3. This stabilizing solution is free from harmful organic solvents and thus doesn’t require labelling according to the REACH regulation Annex XVII 0. SeramunStab® STM3 is especially suitable for the long-term stabilization of HRP activity and antibody reactivity at low conjugate concentrations. Other characteristics like having an excellent stabilization effect over a wide temperature range, a very good signal-to-noise ratio, and a shelf life of 36 months from date of manufacture are also a plus.
News about our company
NO LABELLING REQUIRED FOR NEW STABILIZER Seramun Stab® STM3
NO LABELLING REQUIRED FOR NEW STABILIZER Seramun Stab® NPK
New to the family of Seramun stabilizers for HRP antibody conjugates, protein conjugates and proteins is the ready-to-use product SeramunStab® NPK. This protein-free stabilizing solution is free from harmful organic solvents and thus doesn’t require labelling according to the REACH regulation Annex XVII 0. SeramunStab® NPK is especially suitable for the long-term stabilization of HRP activity and antibody reactivity. Other characteristics like having an excellent stabilization effect over a wide temperature range, a very good signal-to-noise ratio, and a shelf life of 36 months from date of manufacture are also a plus.
NO LABELLING REQUIRED FOR NEW TMB SUBSTRATES
Seramun has launched a new product line called SeraBlue® pure. These TMB substrates are free of harmful organic solvents. According to the REACH regulation Annex XVII 0, no labelling is thus required for these TMB substrates. All SeraBlue® pure substrates have the same characteristics as the well-known SeramunBlau® substrates such as being ready-to-use products, having a high lot-to-lot consistency as well as a long shelf life of up to 36 months and long-term stability at room temperature. Other characteristics like having a high signal yield without precipitation and a high color stability after stopping the reaction process with a low-concentrated acids are also a plus. As the SeraBlue® pure TMB substrates are available with different kinetic rates, these substrates are suitable for basically any laboratory application.
Biotechnology company in Heidesee inaugurates its new production building under the patronage of the former Federal Minister of Economics Brigitte Zypries
Heidesee, 17.09.2021
The biotechnology company Seramun Diagnostica GmbH officially inaugurates its new production building at its location in Heidesee, Germany today under the patronage of the former Federal Minister of Economics and Justice Brigitte Zypries.
The new production building is another milestone in the company’s successful, almost 30-year history. The investment sum of 10 million euros was largely financed from the companies’ own resources - around one million euros was contributed by the business promotion bank of the federal state of Brandenburg. In addition to state-of-the-art production areas and quality control laboratories, cold stores, warehouses as well as offices and documentation areas have been created. The invited guests of the inauguration ceremony have the unique opportunity to view parts of the completed production areas in guided tours before the official start of production. Management and shareholders are available for questions and photos after the opening ceremony at the champagne reception.
ADDITIONAL RESULTS OF SARS-CoV-2 VACCINE STUDY
Why it is important to continue to maintain non-pharmaceutical protective measures even with a high vaccination rate in Germany and why a 3rd booster vaccination might be necessary for older people.An indication of this is shown by the following study in which our product SeraSpot® Anti-SARS-CoV-2 IgG was used.
Schwarz, T., et al., Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis, 2021. 27(8).
https://wwwnc.cdc.gov/eid/article/27/8/21-1145_article
Would you like to know more, look at the study or contact us mathias.schlegel@seramun.com.